| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.028 | 0.6 |